Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

110.71 -3.04 (-2.67%)

Streaming Delayed Price Updated: 12:21 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

71 72 Next >

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

September 01, 2022

Via Benzinga

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗

September 01, 2022

Health Canada has approved Moderna Inc's (NASDAQ:

Via Benzinga

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union

September 01, 2022

From Pfizer Inc.

Via Business Wire

Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗

September 01, 2022

Wall Street Journal

Via Benzinga

Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗

August 31, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...

Via Benzinga

Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older

August 31, 2022

From Pfizer Inc.

Via Business Wire

Pfizer, Moderna Nab FDA Authorization For Updated Covid Boosters ↗

August 31, 2022

Boosters are recommended two months out from the last shot.

Via Investor's Business Daily

Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30 ↗

August 30, 2022

Reuters Taiwan’s China Airlines Orders 16 Boeing 787s

Via Benzinga

US Stock Futures Higher Ahead Of Economic Data, Fed Speakers ↗

August 30, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade as investors digested comments from Federal Reserve Chairman Jerome Powell. Markets closed lower again on Monday, with the...

Via Benzinga

Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report ↗

August 30, 2022

Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

August 26, 2022

Via Benzinga

Pfizer/BioNTech Complete European Submission For Omicron Subvariant Adapted Vaccine ↗

August 26, 2022

Via Benzinga

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine

August 26, 2022

From Pfizer Inc.

Via Business Wire

Moderna Claims Pfizer, BioNTech Stole Its Patented Tech In Covid Shot ↗

August 26, 2022

The lawsuit alleges Comirnaty violates Moderna's patents from 2010-16.

Via Investor's Business Daily

Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know ↗

August 26, 2022

Moderna Inc (NASDAQ: MRNA) has

Via Benzinga

Pfizer And Moderna Are In A Race With Omicron; Will The Vaccine Stocks Be Too Late? ↗

August 26, 2022

The companies hope to launch updated boosters this fall. This is what experts think of their prospects.

Via Investor's Business Daily

AstraZeneca's CEO Says There Are No COVID Regrets, Looks For Oncology Acquisitions ↗

August 24, 2022

In a Reuters report, AstraZeneca Plc's (NASDAQ:

Via Benzinga

Moderna Asks FDA To Sign Off On Its Updated Covid Booster Shot ↗

August 23, 2022

Moderna put the finishing touches on its FDA filing Tuesday, trailing its rivals by a day.

Via Investor's Business Daily

Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers ↗

August 23, 2022

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have

Via Benzinga

Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age

August 23, 2022

From Pfizer Inc.

Via Business Wire

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

Boosters Are Coming For Dangerous Omicron COVID-19 Variant. Here's Who May Be Rolling Them Out ↗

August 22, 2022

Via Benzinga

Face Of US COVID-19 Response, Dr Anthony Fauci To Retire In December ↗

August 22, 2022

Via Benzinga

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine

August 22, 2022

From Pfizer Inc.

Via Business Wire

Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 ↗

August 22, 2022

Reuters Vodafone To Sell Hungarian Business For $1.8B: Report

Via Benzinga

Canada OKs Pfizer COVID-19 Booster For Kids Aged 5-11 Years ↗

August 22, 2022

Via Benzinga

Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions ↗

August 19, 2022

How they handle an upcoming shift in payments will be telling for their tailwind.

Via Investor's Business Daily

Biden Administration To Stop Purchasing COVID-19 Solutions By End Of 2022 ↗

August 17, 2022

Via Benzinga

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

August 15, 2022

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

71 72 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.